Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Chest|July 6, 2020
Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research RegistryAshwin Basavaraj, Radmila Choate, Doreen Addrizzo-Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel SurveyJakko van Ingen, Stefano Aliberti, Claire Andrejak, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2017
Frequency of untreated hypogammaglobulinemia in bronchiectasisMelanie A Ruffner, Timothy R Aksamit, Byron Thomashow, et al.
Thorax|December 16, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisR Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
Thorax|December 19, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summaryR Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
The European Respiratory Journal|March 24, 2018
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statementJakko van Ingen, Timothy Aksamit, Claire Andrejak, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Nutrition and Markers of Disease Severity in Patients With BronchiectasisKatherine A Despotes, Radmila Choate, Doreen Addrizzo-Harris, et al.
Respiratory Medicine|January 5, 2021
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) studyRadmila Choate, Timothy R Aksamit, David Mannino, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
Pathogens and Disease|May 31, 2018
Mycobacterial biomaterials and resources for researchersManzour Hernando Hazbón, Leen Rigouts, Marco Schito, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Chest|July 6, 2020
Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research RegistryAshwin Basavaraj, Radmila Choate, Doreen Addrizzo-Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel SurveyJakko van Ingen, Stefano Aliberti, Claire Andrejak, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2017
Frequency of untreated hypogammaglobulinemia in bronchiectasisMelanie A Ruffner, Timothy R Aksamit, Byron Thomashow, et al.
Thorax|December 16, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisR Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
Thorax|December 19, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summaryR Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
The European Respiratory Journal|March 24, 2018
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statementJakko van Ingen, Timothy Aksamit, Claire Andrejak, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Nutrition and Markers of Disease Severity in Patients With BronchiectasisKatherine A Despotes, Radmila Choate, Doreen Addrizzo-Harris, et al.
Respiratory Medicine|January 5, 2021
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) studyRadmila Choate, Timothy R Aksamit, David Mannino, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
Pathogens and Disease|May 31, 2018
Mycobacterial biomaterials and resources for researchersManzour Hernando Hazbón, Leen Rigouts, Marco Schito, et al.
Pageof 23